ClinicalTrials.Veeva

Menu

Echocardiographic Markers of Atrial Fibrillation Recurrence Post Radiofrequency Ablation (Echo-If-AF)

C

Centro Hospitalar e Universitário de Coimbra, E.P.E.

Status

Enrolling

Conditions

Atrial Fibrillation

Treatments

Procedure: Ablation

Study type

Observational

Funder types

Other

Identifiers

NCT05690529
Echo AF 2021

Details and patient eligibility

About

Determine echocardiographic predictors of atrial fibrillation recurrence post radiofrequency Ablation and evaluate markers of low voltage areas on 3D mapping.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • paroxysmal or persistent ablation

Exclusion criteria

  • previous AF ablation
  • previous left atrial ablation
  • refusal to give informed consent
  • congenital cradiomiopathy

Trial design

100 participants in 2 patient groups

No recurrence
Description:
No recurrence of AF
Treatment:
Procedure: Ablation
Recurrence
Description:
Recurrence of AF
Treatment:
Procedure: Ablation

Trial contacts and locations

1

Loading...

Central trial contact

Diogo Fernandes

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems